| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Dec 25 | A Agilent | Common Stock | Sell | Dispose S | No | No | 149.812 | 2,600 | 389.51 k | 4,973.028 |
| 18 Jun 25 | RCKT Rocket Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 44,220 |
| 14 Mar 25 | A Agilent | Common Stock | Grant | Acquire A | No | No | 121.18 | 1,819 | 220.43 k | 7,549.936 |
| 5 Mar 25 | RCKT Rocket Pharmaceuticals | Common Stock | Other | Acquire J | No | No | 0 | 14,220 | 0.00 | 14,220 |
| 12 Sep 24 | PFE Pfizer | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 45.96 | 126,794 | 5.83 mm | 126,794 |
| 12 Sep 24 | PFE Pfizer | Stock Appreciation Rights Common Stock | Sale back to company | Dispose D | No | No | 45.96 | 126,794 | 5.83 mm | 0 |
| 12 Sep 24 | PFE Pfizer | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 42.3 | 137,760 | 5.83 mm | 137,760 |
| 12 Sep 24 | PFE Pfizer | Stock Appreciation Rights Common Stock | Sale back to company | Dispose D | No | No | 42.3 | 137,760 | 5.83 mm | 0 |
